Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by den Broek, P. J. v.
Right arrow Articles by Mattie, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by den Broek, P. J. v.
Right arrow Articles by Mattie, H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (1999) 44, 193-199
© 1999 The British Society for Antimicrobial Chemotherapy

Intracellular activity of trovafloxacin against Staphylococcus aureus

P. J. van den Broek*, T. G. A. Koot, E. van Strijen and H. Mattie

Leiden University Medical Centre, Department of Infectious Diseases, C5-P, PO Box 9600, 2300 RC Leiden, The Netherlands

The effect of trovafloxacin on Staphylococcus aureus ingested by human granulocytes or monocytes was compared with that on S. aureus in cell-free medium. Maximum growth inhibition (ER,max) by the antibiotic was 0.530 log10/h for S. aureus within granulocytes, 0.912 log10/h for S. aureus within monocytes, and 1.830–1.916 log10/h for S. aureus in medium. EC50, the concentration at which 50% of the maximum growth inhibition is achieved, did not differ significantly under the conditions investigated. After inhibition of intracellular killing by granulocytes with sodium fluoride, the intracellular antibacterial activity of trovafloxacin was still less than that in medium. A 3.4 times higher concentration was needed to achieve the same effect on phagocytosed S. aureus as in cell-free medium. Trovafloxacin binds more strongly to granulocytes than to monocytes, the respective cellular concentrations being 10 and four times higher than that in medium. In conclusion, the activity of trovafloxacin against S. aureus ingested by human granulocytes or monocytes is less than that against S. aureus in cell-free medium and is not related to the cell-associated concentration. Intracellular conditions are not favourable for the antibacterial activity of trovafloxacin.

* Tel: +31-71 5262290; Fax: +31-71 5266758; E-mail: P.J.van_den_Broek{at}thuisnet.leidenuniv.nl


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
H. A. Nguyen, J. Grellet, V. Dubois, M.-C. Saux, and C. Quentin
Factors compromising the activity of moxifloxacin against intracellular Staphylococcus aureus
J. Antimicrob. Chemother., April 1, 2007; 59(4): 755 - 758.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
H. A. Nguyen, J. Grellet, D. Paillard, V. Dubois, C. Quentin, and M.-C. Saux
Factors influencing the intracellular activity of fluoroquinolones: a study using levofloxacin in a Staphylococcus aureus THP-1 monocyte model
J. Antimicrob. Chemother., May 1, 2006; 57(5): 883 - 890.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
O. Krut, H. Sommer, and M. Kronke
Antibiotic-induced persistence of cytotoxic Staphylococcus aureus in non-phagocytic cells
J. Antimicrob. Chemother., February 1, 2004; 53(2): 167 - 173.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
M. H. Gasem, M. Keuter, W. M. V. Dolmans, J. van der Ven-Jongekrijg, R. Djokomoeljanto, and J. W. M. van der Meer
Persistence of Salmonellae in Blood and Bone Marrow: Randomized Controlled Trial Comparing Ciprofloxacin and Chloramphenicol Treatments against Enteric Fever
Antimicrob. Agents Chemother., May 1, 2003; 47(5): 1727 - 1731.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
L. E. T. Stearne, I. C. Gyssens, W. H. F. Goessens, J. W. Mouton, W. J. G. Oyen, J. W. M. van der Meer, and H. A. Verbrugh
In Vivo Efficacy of Trovafloxacin against Bacteroides fragilis in Mixed Infection with either Escherichia coli or a Vancomycin-Resistant Strain of Enterococcus faecium in an Established-Abscess Murine Model
Antimicrob. Agents Chemother., May 1, 2001; 45(5): 1394 - 1401.
[Abstract] [Full Text]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.